We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Millipore Awarded CE Mark

By Biotechdaily staff writers
Posted on 27 Feb 2004
The European Union's Council of Ministers has granted the CE Mark to the clinical sample preparation devices manufactured by Millipore (Billerica, MA, USA). More...
These include the following product families: Amicon, Centriprep, Centricon, and Centrifree centrifugal filter units; and Minicon and Miniplus static concentrators.

These products are used to concentrate and purify macromolecules in human specimens (serum, urine, spinal fluid, and other biologic fluids) prior to final analysis. Under European regulation, all clinical diagnostic devices must bear the CE marking. Millipore is a bioscience company that provides technologies, tools, and services for the discovery, development, and production of new therapeutic drugs.

In an unrelated development, Millipore recently announced the formation of a bioprocessing alliance with HyClone Laboratories (Logan, UT, USA; www.hyclone.com). The collaboration will combine the critical elements required for value-added disposable manufacturing solutions. Biopharmaceutical manufacturers will have only one supplier contact now for the design, development, and validation of disposable manufacturing systems that combine HyClone bioprocess containers with various Millipore disposable separations products.

"Both Millipore and HyClone have worked with pioneering biopharmaceutical companies to validate single-use disposable systems. Our collaborative efforts indicate that these companies are committing significant resources to the validation and implementation of disposable strategies,” said Susan Vogt, president of Millipore's BioPharmaceutical division.




Related Links:
Millipore

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.